These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21982303)

  • 21. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease.
    Gura KM; Lee S; Valim C; Zhou J; Kim S; Modi BP; Arsenault DA; Strijbosch RA; Lopes S; Duggan C; Puder M
    Pediatrics; 2008 Mar; 121(3):e678-86. PubMed ID: 18310188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of parenteral nutrition-associated liver disease: the role of lipid emulsions.
    Nandivada P; Carlson SJ; Chang MI; Cowan E; Gura KM; Puder M
    Adv Nutr; 2013 Nov; 4(6):711-7. PubMed ID: 24228202
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parenteral nutrition-associated cholestasis and triglyceridemia in surgical term and near-term neonates: A pilot randomized controlled trial of two mixed intravenous lipid emulsions.
    Pereira-da-Silva L; Nóbrega S; Rosa ML; Alves M; Pita A; Virella D; Papoila AL; Serelha M; Cordeiro-Ferreira G; Koletzko B
    Clin Nutr ESPEN; 2017 Dec; 22():7-12. PubMed ID: 29415837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enteral fish oil supplementation in the resolution of parenteral nutrition associated cholestasis.
    Thavamani A; Mhanna MJ; Groh-Wargo S; Gulati R; Shekhawat PS
    J Neonatal Perinatal Med; 2019; 12(1):13-20. PubMed ID: 30373963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Parenteral fish oil monotherapy in the management of patients with parenteral nutrition-associated liver disease.
    de Meijer VE; Gura KM; Meisel JA; Le HD; Puder M
    Arch Surg; 2010 Jun; 145(6):547-51. PubMed ID: 20566974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of omega-3 polyunsaturated fatty acids to reverse biopsy-proven parenteral nutrition-associated liver disease in adults.
    Xu Z; Li Y; Wang J; Wu B; Li J
    Clin Nutr; 2012 Apr; 31(2):217-23. PubMed ID: 22035955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Use of an omega-3 fatty acid-based emulsion in the treatment of parenteral nutrition-induced cholestasis in patients with microvillous inclusion disease.
    Fuchs J; Fallon EM; Gura KM; Puder M
    J Pediatr Surg; 2011 Dec; 46(12):2376-82. PubMed ID: 22152886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rifampicin, not vitamin E, suppresses parenteral nutrition-associated liver disease development through the pregnane X receptor pathway in piglets.
    Guthrie G; Stoll B; Chacko S; Lauridsen C; Plat J; Burrin D
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G41-G52. PubMed ID: 31604032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitamin E in New-Generation Lipid Emulsions Protects Against Parenteral Nutrition-Associated Liver Disease in Parenteral Nutrition-Fed Preterm Pigs.
    Ng K; Stoll B; Chacko S; Saenz de Pipaon M; Lauridsen C; Gray M; Squires EJ; Marini J; Zamora IJ; Olutoye OO; Burrin DG
    JPEN J Parenter Enteral Nutr; 2016 Jul; 40(5):656-71. PubMed ID: 25596209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management.
    Gura KM; Duggan CP; Collier SB; Jennings RW; Folkman J; Bistrian BR; Puder M
    Pediatrics; 2006 Jul; 118(1):e197-201. PubMed ID: 16818533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preliminary findings of long-term neurodevelopmental outcomes of infants treated with intravenous fat emulsion reduction for the management of parenteral nutrition-associated cholestasis.
    Blackmer AB; Warschausky S; Siddiqui S; Welch KB; Horn K; Wester A; Warschausky M; Teitelbaum DH
    JPEN J Parenter Enteral Nutr; 2015 Jan; 39(1):34-46. PubMed ID: 25293944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravenous Lipid Emulsions in the Prevention and Treatment of Liver Disease in Intestinal Failure.
    Rochling FA
    Nutrients; 2021 Mar; 13(3):. PubMed ID: 33801970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Index Use of Smoflipid in a Tertiary Intestinal Rehabilitation and Transplantation Program.
    Lam K; Schiano T; Fiel MI; Iyer K
    JPEN J Parenter Enteral Nutr; 2017 Nov; 41(1_suppl):20S-23S. PubMed ID: 29161210
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Improved outcome in neonatal short bowel syndrome using parenteral fish oil in combination with ω-6/9 lipid emulsions.
    Angsten G; Finkel Y; Lucas S; Kassa AM; Paulsson M; Lilja HE
    JPEN J Parenter Enteral Nutr; 2012 Sep; 36(5):587-95. PubMed ID: 22275330
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants.
    Sanchez SE; Braun LP; Mercer LD; Sherrill M; Stevens J; Javid PJ
    J Pediatr Surg; 2013 Mar; 48(3):573-8. PubMed ID: 23480915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parenteral Nutrition-Associated Cholestasis in Premature Infants: Role of Macronutrients.
    Gupta K; Wang H; Amin SB
    JPEN J Parenter Enteral Nutr; 2016 Mar; 40(3):335-41. PubMed ID: 25316680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-Term Outcomes in Children With Intestinal Failure-Associated Liver Disease Treated With 6 Months of Intravenous Fish Oil Followed by Resumption of Intravenous Soybean Oil.
    Wang C; Venick RS; Shew SB; Dunn JCY; Reyen L; Gou R; Calkins KL
    JPEN J Parenter Enteral Nutr; 2019 Aug; 43(6):708-716. PubMed ID: 30411372
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of an Olive Oil-Based Lipid Emulsion Compared With a Soybean Oil-Based Lipid Emulsion on Liver Chemistry and Bile Acid Composition in Preterm Infants Receiving Parenteral Nutrition: A Double-Blind, Randomized Trial.
    Wang Y; Zhou KJ; Tang QY; Hong L; Feng Y; Lu LN; Wang WP; Cai W
    JPEN J Parenter Enteral Nutr; 2016 Aug; 40(6):842-50. PubMed ID: 25560678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis and treatment of parenteral nutrition-associated liver disease.
    Xu ZW; Li YS
    Hepatobiliary Pancreat Dis Int; 2012 Dec; 11(6):586-93. PubMed ID: 23232629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma fatty acids in premature infants with hyperbilirubinemia: before-and-after nutrition support with fish oil emulsion.
    Klein CJ; Havranek TG; Revenis ME; Hassanali Z; Scavo LM
    Nutr Clin Pract; 2013 Feb; 28(1):87-94. PubMed ID: 23319354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.